Cytokinetics Inc. buy Truist Financial Co.
Start price
28.12.23
/
50%
€76.00
Target price
28.12.24
€77.64
Performance (%)
-35.00%
Price
03.09.24
€49.40
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ for Cytokinetics Inc. is performing very badly with a performance of -35.00%. This prediction currently runs until 28.12.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | -1.200% | -1.200% |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at Truist Financial Co. from $60.00 to $86.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€68.00
08.04.24
08.04.24
€79.21
08.04.25
08.04.25
-27.35%
03.09.24
03.09.24